Pfizer reviews

At Pfizer, the statistics function can sometimes feel underprioritized, with competing project deadlines creating constant urgency and limited respect for bandwidth. Following the Seagen merger, there has also been a noticeable shift toward a more aggressive, visibility-driven culture. Meetings can feel performative, with an emphasis on speaking up rather than driving substantive discussion or decision-making. Overall, this environment may be challenging for someone who is focused on producing rigorous, thoughtful statistical work

Bit of a learning curve if you are new to big pharma but is rewarding once you have the process down.